Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza A (H1N1) 2009 MF59-adjuvanted vaccine immunogenicity study
2009-017138-36Phase 4Active
- Sponsor
- St. Elisabeth-Hospital
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Influenza A infection, sponsored by St. Elisabeth-Hospital. Primary endpoints: Humoral immune response (HAI antibody titers), Cellular immune response and 1 more. Started Nov 2009; status: active.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2009-017138-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017138-36.